Rositsa B. Dimova

1.3k total citations
31 papers, 938 citations indexed

About

Rositsa B. Dimova is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Rositsa B. Dimova has authored 31 papers receiving a total of 938 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 14 papers in Hepatology and 6 papers in Infectious Diseases. Recurrent topics in Rositsa B. Dimova's work include Hepatitis C virus research (14 papers), Liver Disease Diagnosis and Treatment (12 papers) and Hepatitis B Virus Studies (6 papers). Rositsa B. Dimova is often cited by papers focused on Hepatitis C virus research (14 papers), Liver Disease Diagnosis and Treatment (12 papers) and Hepatitis B Virus Studies (6 papers). Rositsa B. Dimova collaborates with scholars based in United States, Bulgaria and Austria. Rositsa B. Dimova's co-authors include Andrew H. Talal, Marija Zeremski, Ira M. Jacobson, Marianthi Markatou, Queenie B. Brown, Plamen Neytchev, Neyko Neykov, Peter Filzmoser, Lydia M. Petrovic and Herman Yee and has published in prestigious journals such as JAMA, Gastroenterology and Hepatology.

In The Last Decade

Rositsa B. Dimova

30 papers receiving 915 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rositsa B. Dimova United States 13 502 461 152 98 91 31 938
Alice Langworthy United States 13 1.1k 2.1× 1.1k 2.3× 37 0.2× 59 0.6× 157 1.7× 13 1.8k
Chris H. Gips Netherlands 15 544 1.1× 442 1.0× 47 0.3× 24 0.2× 66 0.7× 29 1.1k
Rui Tato Marinho Portugal 17 960 1.9× 968 2.1× 173 1.1× 65 0.7× 5 0.1× 116 1.4k
William Wong Canada 20 597 1.2× 741 1.6× 139 0.9× 11 0.1× 11 0.1× 92 1.3k
A Theodossi United Kingdom 15 432 0.9× 732 1.6× 40 0.3× 11 0.1× 8 0.1× 27 1.3k
Amrik Shah United States 13 281 0.6× 333 0.7× 112 0.7× 50 0.5× 115 1.3× 19 752
W. Keith Henry United States 13 59 0.1× 364 0.8× 1.3k 8.8× 45 0.5× 243 2.7× 16 2.3k
Alessandra Berzuini Italy 11 168 0.3× 234 0.5× 132 0.9× 32 0.3× 4 0.0× 31 571
Michela Seghezzi Italy 16 27 0.1× 259 0.6× 226 1.5× 60 0.6× 11 0.1× 42 851
Kentaro Matsuura Japan 22 699 1.4× 729 1.6× 83 0.5× 8 0.1× 5 0.1× 88 1.2k

Countries citing papers authored by Rositsa B. Dimova

Since Specialization
Citations

This map shows the geographic impact of Rositsa B. Dimova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rositsa B. Dimova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rositsa B. Dimova more than expected).

Fields of papers citing papers by Rositsa B. Dimova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rositsa B. Dimova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rositsa B. Dimova. The network helps show where Rositsa B. Dimova may publish in the future.

Co-authorship network of co-authors of Rositsa B. Dimova

This figure shows the co-authorship network connecting the top 25 collaborators of Rositsa B. Dimova. A scholar is included among the top collaborators of Rositsa B. Dimova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rositsa B. Dimova. Rositsa B. Dimova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Woo, Emily Jane, Julianne Gee, Paige Marquez, et al.. (2023). Post-authorization safety surveillance of Ad.26.COV2.S vaccine: Reports to the Vaccine Adverse Event Reporting System and v-safe, February 2021–February 2022. Vaccine. 41(30). 4422–4430. 8 indexed citations
2.
Menschik, David, Deborah Thompson, Christopher Jankosky, et al.. (2023). Reporting rates for VAERS death reports following COVID ‐19 vaccination, December 14, 2020–November 17, 2021. Pharmacoepidemiology and Drug Safety. 32(7). 763–772. 1 indexed citations
3.
Wong, Hui‐Lee, Cindy Ke Zhou, Mao Hu, et al.. (2022). Surveillance of COVID-19 vaccine safety among elderly persons aged 65 years and older. Vaccine. 41(2). 532–539. 9 indexed citations
4.
Woo, Emily Jane & Rositsa B. Dimova. (2022). Thrombocytopenia after Ad.26.COV2.S COVID-19 vaccine: Reports to the vaccine adverse event reporting system. Vaccine. 40(31). 4116–4120. 4 indexed citations
5.
Dimova, Rositsa B., et al.. (2020). Systematic Review of Published Meta-Analyses of Vaccine Safety. Statistics in Biopharmaceutical Research. 12(3). 293–302. 4 indexed citations
6.
Zeremski, Marija, et al.. (2016). Improvements in HCV-related Knowledge Among Substance Users on Opioid Agonist Therapy After an Educational Intervention. Journal of Addiction Medicine. 10(2). 104–109. 15 indexed citations
7.
Zeremski, Marija, Rositsa B. Dimova, Jarosław Pillardy, et al.. (2016). Fibrosis Progression in Patients With Chronic Hepatitis C Virus Infection. The Journal of Infectious Diseases. 214(8). 1164–1170. 18 indexed citations
8.
Zeremski, Marija, et al.. (2014). Hepatitis C Virus–Related Knowledge and Willingness to Receive Treatment Among Patients on Methadone Maintenance. Journal of Addiction Medicine. 8(4). 249–257. 37 indexed citations
9.
Zeremski, Marija, et al.. (2014). Intrahepatic and Peripheral CXCL10 Expression in Hepatitis C Virus–Infected Patients Treated With Telaprevir, Pegylated Interferon, and Ribavirin. The Journal of Infectious Diseases. 211(11). 1795–1799. 11 indexed citations
10.
Dimova, Rositsa B.. (2014). Patient Attitudes and Patterns of Self-Medication with Antibiotics – A Cross-Sectional Study in Bulgaria. Macedonian Journal of Medical Sciences. 1 indexed citations
11.
Zeremski, Marija, et al.. (2014). FibroSURE as a noninvasive marker of liver fibrosis and inflammation in chronic hepatitis B. BMC Gastroenterology. 14(1). 118–118. 7 indexed citations
12.
Talal, Andrew H., Rositsa B. Dimova, Randy Seewald, et al.. (2012). Assessment of methadone clinic staff attitudes toward hepatitis C evaluation and treatment. Journal of Substance Abuse Treatment. 44(1). 115–119. 8 indexed citations
13.
Zeremski, Marija, Rositsa B. Dimova, John Sipley, et al.. (2012). IL28B Polymorphism, Pretreatment CXCL10, and HCV RNA Levels Predict Treatment Response in Racially Diverse HIV/HCV Coinfected and HCV Monoinfected Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes. 63(1). 9–16. 6 indexed citations
14.
Dimova, Rositsa B., Marija Zeremski, Ira M. Jacobson, et al.. (2012). Determinants of Hepatitis C Virus Treatment Completion and Efficacy in Drug Users Assessed by Meta-analysis. Clinical Infectious Diseases. 56(6). 806–816. 104 indexed citations
15.
Zeremski, Marija, Rositsa B. Dimova, Jacquie Astemborski, David L. Thomas, & Andrew H. Talal. (2011). CXCL9 and CXCL10 Chemokines as Predictors of Liver Fibrosis in a Cohort of Primarily African-American Injection Drug Users With Chronic Hepatitis C. The Journal of Infectious Diseases. 204(6). 832–836. 47 indexed citations
16.
Dimova, Rositsa B.. (2011). Model Selection Based on Quadratic Distances - An Alternative to Aic.. 1 indexed citations
17.
Martinez, Anthony, Rositsa B. Dimova, Kristen Marks, et al.. (2010). Integrated internist – addiction medicine – hepatology model for hepatitis C management for individuals on methadone maintenance. Journal of Viral Hepatitis. 19(1). 47–54. 47 indexed citations
18.
Zeremski, Marija, Rositsa B. Dimova, Queenie B. Brown, et al.. (2009). Peripheral CXCR3‐Associated Chemokines as Biomarkers of Fibrosis in Chronic Hepatitis C Virus Infection. The Journal of Infectious Diseases. 200(11). 1774–1780. 97 indexed citations
19.
Zeremski, Marija, Lydia M. Petrovic, Luis Chiriboga, et al.. (2008). Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C. Hepatology. 48(5). 1440–1450. 183 indexed citations
20.
Xu, Hua, Marianthi Markatou, Rositsa B. Dimova, Hongfang Liu, & Carol Friedman. (2006). Machine learning and word sense disambiguation in the biomedical domain: design and evaluation issues. BMC Bioinformatics. 7(1). 334–334. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alice Langworthy Breakdown of academic impact, for papers by Chris H. Gips Breakdown of academic impact, for papers by Rui Tato Marinho Breakdown of academic impact, for papers by William Wong Breakdown of academic impact, for papers by A Theodossi Breakdown of academic impact, for papers by Amrik Shah Breakdown of academic impact, for papers by W. Keith Henry Breakdown of academic impact, for papers by Alessandra Berzuini Breakdown of academic impact, for papers by Michela Seghezzi Breakdown of academic impact, for papers by Kentaro Matsuura
Rankless by CCL
2026